Form 4 Tracker
Artiva Biotherapeutics, Inc.
ARTV

8 insider filings · Latest: May 11, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 11, 2026May 13 9:45 PMRA CAPITAL MANAGEMENT, L.P.Director, 10% Owner
Purchase
6,510,416$11.52$75.0M15,203,995(I)

View →

Dec 15, 2025Dec 15 9:18 PMFRED ASLAN
Proposed Sale
12,749$3.30$42.1K

View →

Nov 17, 2025Nov 17 9:29 PMFRED ASLAN
Proposed Sale
6,375$3.25$20.7K

View →

Oct 17, 2025Oct 17 8:17 PMFRED ASLAN
Proposed Sale
25,500$2.77$70.6K

View →

Aug 15, 2025Aug 15 8:24 PMFRED ASLAN
Proposed Sale
25,500$2.70$68.8K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 11, 2026May 13 9:45 PMRA CAPITAL MANAGEMENT, L.P.Director, 10% Owner
Purchase
2,170,138$0.00012,170,138(I)

View →

Feb 18, 2026Feb 20 2:50 AMElaine K. SorgDirector
Grant/Award
27,500$4.1527,500(D)

View →